BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 19745764)

  • 1. Characterization of pneumonitis in patients with advanced non-small cell lung cancer treated with everolimus (RAD001).
    White DA; Schwartz LH; Dimitrijevic S; Scala LD; Hayes W; Gross SH
    J Thorac Oncol; 2009 Nov; 4(11):1357-63. PubMed ID: 19745764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninfectious pneumonitis after everolimus therapy for advanced renal cell carcinoma.
    White DA; Camus P; Endo M; Escudier B; Calvo E; Akaza H; Uemura H; Kpamegan E; Kay A; Robson M; Ravaud A; Motzer RJ
    Am J Respir Crit Care Med; 2010 Aug; 182(3):396-403. PubMed ID: 20194812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: incidence, radiographic findings and correlation with clinical outcome.
    Dabydeen DA; Jagannathan JP; Ramaiya N; Krajewski K; Schutz FA; Cho DC; Pedrosa I; Choueiri TK
    Eur J Cancer; 2012 Jul; 48(10):1519-24. PubMed ID: 22483544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-Related Pneumonitis During Mammalian Target of Rapamycin Inhibitor Therapy: Radiographic Pattern-Based Approach in Waldenström Macroglobulinemia as a Paradigm.
    Nishino M; Boswell EN; Hatabu H; Ghobrial IM; Ramaiya NH
    Oncologist; 2015 Sep; 20(9):1077-83. PubMed ID: 26205737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-related pneumonitis during mammalian target of rapamycin inhibitor therapy in patients with neuroendocrine tumors: a radiographic pattern-based approach.
    Nishino M; Brais LK; Brooks NV; Hatabu H; Kulke MH; Ramaiya NH
    Eur J Cancer; 2016 Jan; 53():163-70. PubMed ID: 26760924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors.
    Soria JC; Shepherd FA; Douillard JY; Wolf J; Giaccone G; Crino L; Cappuzzo F; Sharma S; Gross SH; Dimitrijevic S; Di Scala L; Gardner H; Nogova L; Papadimitrakopoulou V
    Ann Oncol; 2009 Oct; 20(10):1674-81. PubMed ID: 19549709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of pneumocystis pneumonia associated with everolimus therapy for renal cell carcinoma.
    Saito Y; Nagayama M; Miura Y; Ogushi S; Suzuki Y; Noro R; Minegishi Y; Kimura G; Kondo Y; Gemma A
    Jpn J Clin Oncol; 2013 May; 43(5):559-62. PubMed ID: 23423809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial pneumonitis caused by everolimus: a case-cohort study in renal transplant recipients.
    Baas MC; Struijk GH; Moes DJ; van den Berk IA; Jonkers RE; de Fijter JW; van der Heide JJ; van Dijk M; ten Berge IJ; Bemelman FJ
    Transpl Int; 2014 May; 27(5):428-36. PubMed ID: 24484452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Everolimus-associated pneumonitis in 3 heart transplant recipients.
    Otton J; Hayward CS; Keogh AM; Glanville AR; Macdonald PS
    J Heart Lung Transplant; 2009 Jan; 28(1):104-6. PubMed ID: 19134540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstitial pneumonitis as an adverse reaction to mTOR inhibitors.
    Molas-Ferrer G; Soy-Muner D; Anglada-Martínez H; Riu-Viladoms G; Estefanell-Tejero A; Ribas-Sala J
    Nefrologia; 2013; 33(3):297-300. PubMed ID: 23712219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Everolimus and erlotinib as second- or third-line therapy in patients with advanced non-small-cell lung cancer.
    Papadimitrakopoulou VA; Soria JC; Jappe A; Jehl V; Klimovsky J; Johnson BE
    J Thorac Oncol; 2012 Oct; 7(10):1594-601. PubMed ID: 22968184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus and everolimus induced pneumonitis in adult renal allograft recipients: experience in a center.
    Rodríguez-Moreno A; Ridao N; García-Ledesma P; Calvo N; Pérez-Flores I; Marques M; Barrientos A; Sánchez-Fructuoso AI
    Transplant Proc; 2009; 41(6):2163-5. PubMed ID: 19715862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian target of rapamycin (mTOR) inhibitor-associated non-infectious pneumonitis in patients with renal cell cancer: predictors, management, and outcomes.
    Atkinson BJ; Cauley DH; Ng C; Millikan RE; Xiao L; Corn P; Jonasch E; Tannir NM
    BJU Int; 2014 Mar; 113(3):376-82. PubMed ID: 24053120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial.
    Motzer RJ; Escudier B; Oudard S; Hutson TE; Porta C; Bracarda S; Grünwald V; Thompson JA; Figlin RA; Hollaender N; Urbanowitz G; Berg WJ; Kay A; Lebwohl D; Ravaud A;
    Lancet; 2008 Aug; 372(9637):449-56. PubMed ID: 18653228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gefitinib-induced pneumonitis in non-small cell lung cancer: radiological and clinical findings in five patients.
    Park HS; Lee HJ; Im JG; Goo JM; Lee CH; Park CM; Chun EJ
    Clin Imaging; 2007; 31(5):306-12. PubMed ID: 17825737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma.
    Tobinai K; Ogura M; Maruyama D; Uchida T; Uike N; Choi I; Ishizawa K; Itoh K; Ando K; Taniwaki M; Shimada N; Kobayashi K
    Int J Hematol; 2010 Nov; 92(4):563-70. PubMed ID: 20972652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of sirolimus-induced pneumonitis after conversion to everolimus.
    Rehm B; Keller F; Mayer J; Stracke S
    Transplant Proc; 2006 Apr; 38(3):711-3. PubMed ID: 16647451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Everolimus-induced pneumonitis in neuroendocrine neoplasms: correlation of CT findings and clinical signs.
    Fehrenbach U; Rodríguez-Laval V; Jann H; Fernández CMP; Pavel M; Denecke T
    Acta Radiol; 2021 Aug; 62(8):1006-1015. PubMed ID: 32819165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual radiological presentation of sirolimus-associated pneumonitis.
    Huang LK; Tsai MJ; Chang SC
    J Chin Med Assoc; 2013 Oct; 76(10):588-92. PubMed ID: 23876831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer.
    Nishino M; Chambers ES; Chong CR; Ramaiya NH; Gray SW; Marcoux JP; Hatabu H; Jänne PA; Hodi FS; Awad MM
    Cancer Immunol Res; 2016 Apr; 4(4):289-93. PubMed ID: 26865455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.